Researchers develop milk that protects against HIV

October 17, 2012
Milk that protects against HIV
Marit Kramski in the lab with frozen milk delivered from the farm. Credit: Damian Purcell

Melbourne researchers have developed cows' milk that protects human cells from HIV.

The milk contains antibodies which defend against (HIV).

The next step will be to develop it into a cream which women can apply to protect themselves from contracting HIV from sexual partners.

Melbourne University's Dr Marit Kramski and colleagues found that using cows to produce HIV-inhibiting antibodies is cheaper than existing methods.

They worked with Australian Immuron Ltd to develop the milk. The scientists vaccinated pregnant cows with an and studied the first milk that cows produced after giving birth.

The first milk, called the colostrum, is naturally packed with antibodies to protect the newborn calf from infections. The vaccinated cows produced in their milk.

"We were able to harvest antibodies specific to the HIV from the milk," said Marit, who is presenting her research this week as one of the winners of Fresh Science—a national program for early-career scientists.

"We have tested these antibodies and found in our laboratory experiments that they bind to HIV and that this inhibits the virus from infecting and entering ," she said.

Cows cannot contract HIV. But their  immune systems develop antibodies against the foreign protein.

The HIV-inhibiting antibodies from cows' milk will be developed into a cream called a microbicide that is applied into the vagina before and /or after sex to protect women from contracting sexually transmitted infections. Other microbicides are being developed around the world but the antibodies in this research are easier and cheaper to produce, providing a new HIV-prevention strategy.

"We hope that our anti-HIV milk antibodies will provide a user-friendly, female-controlled, safe and effective tool for the prevention of sexually acquired ," Marit said.

"If proven effective in humans, it will empower women to protect themselves against HIV."

About 30 million people are living with HIV globally and there is presently no effective vaccine for humans.The research was supported by the Australian Centre for HIV and Hepatitis Virology Research and the NHMRC.

Marit and her colleagues are now developing plans for animal and human studies.

Marit Kramski is one of 12 early career scientists unveiling their research to the public for the first time thanks to Fresh Science, a national program sponsored by the Australian Government.

Explore further: Breast milk antibody fights HIV but needs boost

More information: aac.asm.org/content/early/2012 … AC.00453-12.abstract

Related Stories

Breast milk antibody fights HIV but needs boost

September 19, 2011
Breast milk antibody both neutralizes human immunodeficiency virus (HIV) and kills HIV-infected cells, according to a paper in the September 2011 issue of the Journal of Virology.

Researchers discuss challenges to developing broadly protective HIV vaccines

September 7, 2011
The human body can produce powerful antibodies that shield cells in the laboratory against infection by an array of HIV strains. In people, however, recent research shows that these broadly neutralizing antibodies are not ...

Insight into HIV immunity may lead to vaccine

May 6, 2011
(Medical Xpress) -- Latest insights into immunity to HIV could help to develop a vaccine to build antibodies’ defences against the disease, a University of Melbourne study has found.

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.